The article gives literature data systematic analysis (20 Russian and 47 foreign literature sources) on the issue of rehabilitation of patients with hip fracture (HF) against the background of osteoporosis (OP) and the role of pathogenetic therapy with zoledronic acid in the complex rehabilitation of such patients. Literature data testify to the high prevalence and medical and social significance of osteoporotic HF in Russia and abroad. The need to develop effective methods for the rehabilitation of patients with OP is due to the demand for patient’s life quality recovery in short terms, treatment cost reduction and death risk reduction, the highest during the first year after a pathological HF. The main objective of rehabilitation measures after osteoporotic HF is to reduce the likelihood of disability and death of the patient that is extremely high in the first months after the fracture – about 10% of elderly patients die in the first 3 months after HF. The effectiveness of medical rehabilitation of patients with HF depends on the surgical treatment and mobilization time frames. Exercises are recommended to strengthen the muscles – knee extensors in the first 2–5 days after surgical treatment of osteoporotic HF. After 3 weeks, progressive strength training should be included in rehabilitation programs to improve the functional capabilities of patients. Conclusion. Given the high risk of recurrent fractures in patients with osteoporosis undergoing rehabilitation after HF, the appointment of pharmacological therapy for OP, primarily zoledronic acid at a dose of 5 mg once a year, should be a mandatory addition to physical therapy procedures.
osteoporosis, hip fracture, medical rehabilitation, quality of life, physical functioning, zoledronic acid
1. Belaya Zh.E., Rozhinskaya L.Ya., Grebennikova T.A. Kratkoe izlozhenie proekta federal'nyh klinicheskih rekomendaciy po osteoporozu. Osteoporoz i osteopatii. 2020; 23(2): 4-21.
2. Kanis J.A., Cooper C., Rizzoli R. et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International. 2019; (30): 3-44. https://doi.org/10.1007/s00198-018-4704-5
3. Lesnyak O.M. Audit sostoyaniya problemy osteoporoza v stranah Vostochnoy Evropy i Central'noy Azii 2011. Osteoporoz i osteopatii. 2011; (2): 3-6.
4. Lesnyak O.M. Social'no-ekonomicheskoe bremya osteoporoza dlya Rossiyskoy Federacii. Sbornik tezisov IV Rossiyskogo kongressa po osteoporozu. Osteoporoz i osteopatii. 2010; (1): 27 s.
5. Lesnyak O.M., Baranova I.A., Belova K.Yu. Osteoporoz v Rossiyskoy Federacii: epidemiologiya, mediko-social'nye i ekonomicheskie aspekty problemy (obzor literatury). Travmatologiya i ortopediya Rossii. 2018; 24(1): 155-168. https://doi.org/10.21823/2311-2905-2018-24-1-155-168
6. Ershova O.B., Belova K.Yu., Belov M.V. Epidemiologiya perelomov proksimal'nogo otdela bedrennoy kosti u gorodskogo naseleniya Rossiyskoy Federacii: rezul'taty mnogocentrovogo issledovaniya. Materialy nauchno-prakticheskoy konferencii «Osteoporoz vazhneyshaya mul'tidisciplinarnaya problema XXI veka». Sankt-Peterburg, 23-25 sentyabrya. 2012: 23-27.
7. Lesnyak O., Ershova O., Belova K. et al. Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Archives of Osteoporosis. 2012; (7): 67-73. https://doi.org/10.1007/s11657-012-0082-3
8. Komissarov A.N., Pal'shin G.A., Rodionova S.S. Chastota perelomov proksimal'nogo otdela bedrennoy kosti sredi zhiteley goroda Yakutska. Osteoporoz i osteopatii. 2004; (1): 2-3.
9. Seryapina Yu.V., Fedyaev D.V., Musina N.Z. Zabolevaemost' perelomami proksimal'nogo otdela bedrennoy kosti pacientov v vozraste 60 let i starshe v Rossiyskoy Federacii. Medicinskie tehnologii. Ocenka i vybor. 2020; 40(2): 9-66. https://doi.org/10.17116/medtech20204002159
10. Belova K.Yu., Lesnyak O.M., Ershova O.B., Belov M.V., Gladkova E.N. Zabolevaemost' perelomami proksimal'nogo otdela bedrennoy kosti pacientov v vozraste 60 let i starshe v Rossiyskoy Federacii. Medicinskie tehnologii. Ocenka i vybor. 2021; (1): 73-76.
11. Bessette L., Jean S., Lapointe-Garant M.P. et al. Direct medical costs attributable to peripheral fractures in Canadian post-menopausal women. Osteoporosis International. 2012; 23(6): 1757-1768. https://doi.org/10.1007/s00198-011-1785-9
12. Aziziyeh R., Amin M., Habib M. et al. A scorecard for osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina. Archives of Osteoporosis. 2019; 14(1): 69 p. https://doi.org/10.1007/s11657-019-0622-1
13. Williamson S., Landeiro F., McConnell T. et al. Costs of fragility hip fractures globally: a systematic review and meta-regression analysis. Osteoporosis International. 2017; 28(10): 2791-2800. https://doi.org/10.1007/s00198-017-4153-6
14. Ilieva E. What are the effects of exercise for improving outcomes after osteoporotic vertebral fracture? - A Cochrane Review summary with commentary. Journal of Musculoskeletal and Neuronal Interactions. 2020; 20(2): 165-167.
15. LeBlanc E.S., Hillier T.A., Pedula K.L. et al. Hip fracture and increased short-term but not long-term mortality in healthy older women. Archives of Internal Medicine. 2011; 171(20): 1831-1837. https://doi.org/10.1001/archinternmed.2011.447
16. Cooper C. The crippling consequences of fractures and their impact on quality of life. The American Journal of Medicine. 1997; 103(S.2A): 12-19.
17. Cooper C., Cole Z.A., Holroyd C.R. et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporosis International. 2011; 22(5): 1277-1288. https://doi.org/10.1007/s00198-011-1601-6
18. Nikitovic M., Wodchis W.P., Krahn M.D., Cadarette S.M. Direct health-care costs attributed to hip fractures among seniors: a matched cohort study. Osteoporosis International. 2013; 24(2): 659-669. https://doi.org/10.1007/s00198-012-2034-6
19. De Rui M., Veronese N., Manzato E., Sergi G. Role of comprehensive geriatric assessment in the management of osteoporotic hip fracture in the elderly: an overview. Disability and Rehabilitation. 2013; 35(9): 758-765. https://doi.org/10.3109/09638288.2012.707747
20. Dyer S.M., Crotty M., Fairhall N. et al. Fragility Fracture Network (FFN) Rehabilitation Research Special Interest Group. A critical review of the longterm disability outcomes following hip fracture. BMC Geriatrics. 2016; 16(1): 158 p. https://doi.org/10.1186/s12877-016-0332-0
21. Men'shikova L.V., Hramcova N.A. Retrospektivnoe izuchenie chastoty perelomov proksimal'nogo otdela bedra i distal'nogo otdela predplech'ya sredi zhiteley Irkutskoy oblasti. Osteoporoz i osteopatii. 2000; (4): 5-8.
22. Markova T.N., Markov D.S., Markelova T.N. Rasprostranennost' deficita vitamina D i faktorov riska osteoporoza u lic molodogo vozrasta. Vestnik Chuvashskogo universiteta. 2012; (3): 441-445.
23. Gladkova E.N., Hodyrev V.N., Lesnyak O.M. Analiz dvigatel'noy aktivnosti posle pereloma proksimal'nogo otdela bedra v populyacii gorodskih zhiteley Sverdlovskoy oblasti. Materialy nauchno-prakticheskoy konferencii «Osteoporoz vazhneyshaya mul'tidisciplinar- naya problema XXI veka». Sankt-Peterburg, 23-25 sentyabrya. 2012: 15-19.
24. Bower E.S., Wetherell J.L., Petkus A.J., Rawson K.S., Lenze E.J. Fear of falling after hip fracture: prevalence, course, and relationship with one-year functional recovery. The American Journal of Geriatric Psychiatry. 2016; 24(12): 1228-1236. https://doi.org/10.1016/j.jagp.2016.08.006
25. Moraes S.A., Furlanett E.C., Ricci N.A., Perracini M.R. Sedentary behavior: barriers and facilitators among older adults after hip fracture surgery. A qualitative study. Brazilian Journal of Physical Therapy. 2020; 24(5): 407-414. https://doi.org/10.1016/j.bjpt.2019.07.001
26. Bischoff-Ferrari H.A., Dawson-Hughes B., Platz A. et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Archives of Internal Medicine. 2010; 170(9): 813-820. https://doi.org/10.1001/archinternmed.2010.67
27. Cristancho P., Lenze E.J., Avidan M.S., Rawson K.S. Trajectories of depressive symptoms after hip fracture. Psychological Medicine. 2016; 46(7): 1413-1425. https://doi.org/10.1017/S0033291715002974
28. Falaschi P., Marsh D. The Management of Older Patients with Fragility Fractures. Second Edition. Practical Issues in Geriatrics (eBook). Springer. 2021: 357 p. https://doi.org/10.1007/978-3-030-48126-1
29. Abrahamsen B., van Staa T., Ariely R., Ariely R., Olson M., Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporosis International. 2009; 20(10): 1633-1650. https://doi.org/10.1007/s00198-009-0920-3
30. Grønskag A.B., Romundstad P., Forsmo S., Langhammer A., Schei B. Excess mortality after hip fracture among elderly women in Norway. Osteoporosis International. 2012; 23(6): 1807-1811. https://doi.org/10.1007/s00198-011-1811-y
31. Koh G.C.-H., Tai B.C., Ang L.-W., Heng D., Yuan J.M., Koh W.P. All-cause and cause-specific mortality after hip fracture among Chinese women and men. Osteoporosis International. 2013; 24(7): 1981-1989. https://doi.org/10.1007/s00198-012-2183-7
32. Belova K.Yu., Ershova O.B., Ganert O.A. Analiz letal'nosti posle perelomov proksimal'nogo otdela bedra sredi zhiteley goroda Yaroslavlya v vozraste 50 let i starshe. Materialy nauchno-prakticheskoy konferencii «Osteoporoz vazhneyshaya mul'tidisciplinarnaya problema XXI veka». Sankt-Peterburg, 23-25 sentyabrya. 2012: 11-15.
33. Mihaylov E.E., Benevolenskaya L.I., Barkova T.V. Epidemiologicheskaya harakteristika perelomov konechnostey v populyacionnoy vyborke lic 50 let i starshe. Osteoporoz i osteopatii. 1998; (2): 2-6.
34. Mihaylov E.E., Benevolenskaya L.I., Mylov N.M. Rasprostranennost' perelomov pozvonochnika v populyacionnoy vyborke lic 50 let i starshe. Vestnik travmatologii i ortopedii im N.N. Priorova. 1999; (3): 20-27.
35. Warhurst S., Labbe-Hubbard S., Yi M. et al. Patient haracteristics, treatment outcomes and rehabilitation practices for patients admitted with hip fractures using multiple data set analysis. New Zealand Medical Journal. 2020; 133(1526): 31-44.
36. Leslie W.D., Brennan S.L., Prior H.J., Lix L.M., Metge C., Elias B. The contributions of First Nations ethnicity, income, and delays in surgery on mortality post-fracture: a population-based analysis. Osteoporosis International. 2013; 24(4): 1247-1256. https://doi.org/10.1007/s00198-012-2099-2
37. Vidal E.I.O., Moreira-Filho D.C., Pinheiro R.S. et al. Delay from fracture to hospital admission: a new risk factor for hip fracture mortality? Osteoporosis International. 2012; 23(12): 2847-2853. https://doi.org/10.1007/s00198-012-1917-x
38. Carlin L., Sibley K., Jenkinson R. et al. Exploring Canadian surgeons’ decisions about postoperative weight bearing for their hip fracture patients. Journal of Evaluation in Clinical Practice. 2018; 24(1): 42-47. https://doi.org/10.1111/jep.12645
39. Kerschan-Schindl K. Prevention and rehabilitation of osteoporosis. Wiener Medizinische Wochenschrift. 2016; 166(1-2): 22-27. https://doi.org/10.1007/s10354-015-0417-y
40. Kammerlander S., Pfeufer D., Lisitano L.A., Mehaffey S., Böcker W., Neuerburg C. Inability of older adult patients with hip fracture to maintain postoperative weight-bearing restrictions. The Journal of Bone and Joint Surgery. 2018; 100(11): 936-941. https://doi.org/10.2106/JBJS.17.01222
41. Siu A.L., Penrod J.D., Boockvar K.S. et al. Early ambulation after hip fracture: Effects on function and mortality. Archives of Internal Medicine. 2006; 166(7): 766-771. https://doi.org/10.1001/archinte.166.7.766
42. Kochish A.Yu., Lesnyak O.M., Belen'kiy I.G. i dr. Kommentarii k rekomendaciyam EULAR/EFORT po lecheniyu pacientov starshe 50 let s nizkoenergeticheskimi perelomami i profilaktike u nih povtornyh perelomov. Geniy ortopedii. 2019; 25(1): 6-14. https://doi.org/10.18019/1028-4427-2019-25-1-6-14
43. Kronborg L., Bandholm T., Palm H., Kehlet H., Kristensen M.T. Feasibility of progressive strength training implemented in the acute ward after hip fracture surgery. PLoS One. 2014; 9(4): e93332 p. https://doi.org/10.1371/journal.pone.0093332
44. Mitchell S.L., Stott D.J., Martin B.J., Grant S.J. Randomized controlled trial of quadriceps training after proximal femoral fracture. Clinical Rehabilitation. 2001; 15(3): 282-290. https://doi.org/10.1191/026921501676849095
45. Overgaard J., Kristen M.T. Feasibility of progressive strength training shortly after hip fracture surgery. World Journal of Orthopedics. 2013; 4(4): 248-258. https://doi.org/10.5312/wjo.v4.i4.248
46. Monticone M., Ambrosini E., Brunati R. et al. How balance task-specific training contributes to improving physical function in older subjects undergoing rehabilitation following hip fracture: a randomized controlled trial. Clinical Rehabilitation. 2018; 32(3): 340-351. https://doi.org/10.1177/0269215517724851
47. Gillespie L.D., Robertson M.C., Gillespie W.J. et al. Interventions for preventing falls in older people living in the community. Cochrane Database of Systematic Reviews. 2012; (12): CD007146 p. https://doi.org/10.1002/14651858.CD007146.pub3
48. El-Khoury F., Cassou B., Charles M.A., Dargent-Molina P. The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials. The BMJ. 2013; (347): f6234 p.
49. Cameron I.D., Gillespie L.D., Robertson M.C. et al. Interventions in preventing falls in older people in care facilities and hospitals. Cochrane Database of Systematic Reviews. 2012; (12): CD005465 p. https://doi.org/10.1002/14651858.CD005465.pub3
50. Héquette-Ruz R., Beuscart J.-B., Ficheur G. et al. Hip fractures and characteristics of living area: a fine-scale spatial analysis in France. Osteoporosis International. 2020; 31(7): 1353-1360. https://doi.org/10.1007/s00198-020-05363-7
51. George A.A., Way M., Varughese I. The effect of pre-operative medical co-morbidities on rehabilitation outcomes following surgery for hip fracture management in geriatric populations. Geriatric Orthopaedic Surgery & Rehabilitation. 2020; (11): 1-4. https://doi.org/10.1177/2151459320964030
52. Borinskiy S.Yu., Shavieva I.A. Kompleksnaya reabilitaciya pacientov s osteoporozom posle endoprotezirovaniya tazobedrennogo sustava v starshih vozrastnyh gruppah. V knige: II Mezhdunarodnyy kongress associacii revmoortopedov. Tezisy dokladov kongressa. Associaciya revmoortopedov. 2018: 22-24.
53. Mazurov V.I., Lesnyak O.M., Belova K.Yu. Algoritmy vybora terapii osteoporoza pri okazanii pervichnoy mediko-sanitarnoy pomoschi i organizacii l'gotnogo lekarstvennogo obespecheniya otdel'nyh kategoriy grazhdan, imeyuschih pravo na poluchenie gosudarstvennoy social'noy pomoschi. Sistemnyy obzor i rezolyuciya Ekspertnogo soveta Rossiyskoy associacii po osteoporozu. Profilakticheskaya medicina. 2019; 22(1); 57-65. https://doi.org/10.17116/profmed20192201157
54. Conley R.B., Adib G., Adler R.A. et al. Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition. The Journal of Bone and Mineral Research. 2020; 35(1): 36-52. https://doi.org/10.1002/jbmr.3877
55. Shibasaki K., Asahi T., Kuribayashi M. et al. Potential prescribing omissions of anti-osteoporosis drugs is associated with rehabilitation outcomes after fragility fracture: Retrospective cohort study. Geriatrics & Gerontology International. 2021; 21(5): 386-391. https://doi.org/10.1111/ggi.14145
56. Black D.M., Delmas P.D., Eastell R. et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. The New England Journal of Medicine. 2007; 356(18): 1809-1822. https://doi.org/10.1056/NEJMoa067312
57. Lyles K.W., Colon-Emeric C.S., Magaziner J.S. et al. Zoledronic acid and clinical fractures and mortality after hip fracture. The New England Journal of Medicine. 2007; 357(18): 1799-1809. https://doi.org/10.1056/NEJMoa074941
58. Marchenkova L.A., Dreval' A.V., Baharev I.V. Effektivnost' i perenosimost' rezoklastina FC (5 mg) pri lechenii osteoporoza: retrospektivnyy analiz klinicheskogo opyta primeneniya preparata v Rossii. Osteoporoz i osteopatii. 2014; (3): 22-26.
59. Hadji P., Ziller V., Gamerdinger D., Spieler W., Articus K., Baier M., Moericke R., Kann P.H. Quality of life and health status with zoledronic acid and generic alendronate - a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass. Osteoporosis International. 2012; 23(7): 2043-2051. https://doi.org/10.1007/s00198-011-1834-4
60. Hamdy RC. Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass. Drug Design, Development and Therapy. 2010; (4): 321-335. https://doi.org/10.2147/DDDT.S6287
61. Grey A., Bolland M.J. The effect of treatments for osteoporosis on mortality. Osteoporosis International. 2013; (24): 1-6. https://doi.org/10.1007/s00198-012-2176-6
62. Huang S., Lin H., Zhu X., Chen X., Fan L., Liu C. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis. Endokrynologia Polska. 2014; 65(2): 96-104. https://doi.org/10.5603/EP.2014.0014
63. Black D.M., Reid I.R., Boonen S. et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal fracture trial (PFT). The Journal of Bone and Mineral Research. 2012; (2): 243-254. https://doi.org/10.1002/jbmr.1494
64. Golounina O.O., Belaya Zh.E. Bisfosfonaty: 50 let v medicinskoy praktike. Consilium Medicum. 2020; 22(4): 66-73.
65. Marchenkova L.A., Makarova E.V., Gerasimenko M.Yu., Evstigneeva I.S. Ocenka riska osteoporoticheskih perelomov i rasprostranennosti osteoporoza u pacientov v vozraste 50 let i starshe, prohodyaschih medicinskuyu reabilitaciyu. Fizioterapiya, bal'neologiya i reabilitaciya. 2020; 19(1): 13-19.
66. Kristensen P. K., Ehrenstein V., Shetty N., Pedersen A.B. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better? Osteoporosis International. 2019; 30(9): 1817-1825. https://doi.org/10.1007/s00198-019-05066-8
67. Bernatz J.T., Brooks A.E., Squire M.W., Illgen R.I. 2nd, Binkley N.C., Anderson P.A. Osteoporosis is common and undertreated prior to total joint arthroplasty. The Journal of Arthroplasty. 2019; 34(7): 1347-1353. https://doi.org/10.1016/j.arth.2019.03.044
